free web hit counter Press "Enter" to skip to content

Testosterone Blocks Breast Cancer– & Makes You Feel Great

There is a natural decline of sex hormonal agents as a female ages. Testosterone is the dominant hormone in young healthy females and is 5 to 20 times more abundant than estrogen. As women age and enter menopause we picked estrogen as a primary hormone for replacement. It is basically a guess.In the 1940s they discovered that taking sheep ovaries and grinding them up would provide ladies relief of menopausal signs. Then they found they could draw out estrogen from the urine of a five-year-old pregnant horse, and that the estrogen relieved menopause symptoms.( The brand name Premarin represents PRE gnant MAR e urine.)In 2002, it was discovered that female on Premarin and Provera, the biggest-selling drugs at the time, had a minor increase in the threat of breast cancer. This caused a 50 % drop in the usage of hormone replacement therapy.There’s a lot to this story, and I speak about it in my book, Testosterone

: Strong Enough for a Man, Made for a Woman. However here I’ll talk particularly about how possibly testosterone ought to have been the hormone we were replacing, and how testosterone substantially minimizes a woman’s threat of establishing breast cancer.Early animal studies showed that testosterone worked much better than anticancer drugs for reducing the advancement of breast cancer development, called breast cell expansion.(Menopause Vol 10, No. 4, 2003)Later studies examined about 100 females and the effect of hormonal agent replacement on the breast over 6 months. Estrogen

is understood to stimulate breast cell proliferation, which can be considered a precursor to the possible development of breast cancer. Testosterone had been shown to lower or minimize that expansion of the breast.In this study, the women were put on estrogen and their breast cell expansion was assessed. There was an increase by 500%. When testosterone was included,

breast cell proliferation totally stopped.(Menopause, Vol. 14, No. 2, 2007)So these research studies revealed that testosterone would block expansion of breast tissue. Exactly what about the impact of testosterone when integrated with hormonal agent replacement in the real development of breast

cancer?Breast cancer is relatively typical. About one in seven females will eventually develop breast cancer, the majority of frequently after age 50. There is an analytical measurement that is frequently utilized for evaluating rates of breast cancer called”100,000 woman-years.”This is a means of comparing interventions. It could be the study of 100,000 ladies for one year, or 10,000 women for 10 years. When comparing statistics, researchers use mathematics to obtain to the 100,000 woman-year measurement.In large clinical studies, breast cancer rates with or without hormonal agent replacement is about 350-520 per 100,000 woman-years. There were 2 kinds of standard hormonal agent replacement therapy. Estrogen alone was used in females with a prior hysterectomy. Estrogen and progestin were utilized when the female’s

uterus was undamaged. The function of the progestin is to avoid menstruation.Progestin is a synthetic drug that imitates progesterone the hormone, to protect the uterus. Progestin in and of itself has a connect to breast cancer. Progesterone does not. In other words, progesterone the hormone is breast cancer protective, and progestin the drug has a slight stimulation of breast cancer.An Australian study included testosterone to the

traditional estrogen/progestin hormone replacement therapy. They discovered that adding testosterone to estrogen and progestin lowered the breast cancer rate to 293 per 100,000 woman-years. Even more impressive, in females on estrogen and testosterone just(without the progestin drug), the rates of breast cancer was up to 115 per 100,000 woman-years. That has to do with a 75% reduction.(Menopause: The Journal of The North American Menopause Society Vol. 11, No. 5, pp. 531-535, 2004)Taking this even more, a five-year study was reported on using testosterone only for females in pre-menopause in addition to post-menopause. Testosterone is the dominant hormonal agent in a young healthy female. And testosterone can be converted into estrogen by an enzyme called aromatase. This is done at the cellular level.

The idea is that if a female is offered testosterone, she can transform it into estrogen where needed, which

is what takes place naturally in the body.In this research study the ladies were given testosterone implants. It’s called a pellet and is about the size of a grain of

rice. It’s inserted under the skin and breaks down naturally over about 3 months.In this huge research study, all symptoms of menopause or pre-menopause were improved. There were no adverse drug events.The breast cancer rate in the geographic area where this research study happened has to do with 300 per 100,000 woman-years. Females who continued to use testosterone during the 5 years

had a reduced incidence of breast cancer of 73 per 100,000 woman-years. That’s about a 75 %decrease in the rate of breast cancer.(Maturitas 76 (2013)342– 349 )Testosterone, with or without estrogen, is reliable for relief of menopause or perimenopause symptoms. Progesterone the hormonal agent(not progestin the drug) should be used where required.

Alone or together these hormones enhance quality of life in addition to enhance all signs of menopause including: Menopause Signs hot flashes sweating sleep disruption heart discomfort depressive mood irritation stress and anxiety Premenstrual Syndrome Signs fatigue amnesia migraine headaches vaginal dryness sexual problems bone discomfort and

loss If you wish to consider hormonal agent replacement to enhance the symptoms connected with hormone decrease, however are concerned about health threats, I hope this answers some questions.While there are some health threats connected with taking hormonal agent replacement drugs, particularly when beginning them at a much older age, this danger does not accompany actual hormones. The danger of breast cancer, heart

disease and other illness